middle.news
Largest Global Study Validates TruScreen as Superior Cervical Cancer Screening Tool
8:12am on Wednesday 11th of February, 2026 AEDT
•
Healthcare
Read Story
Largest Global Study Validates TruScreen as Superior Cervical Cancer Screening Tool
8:12am on Wednesday 11th of February, 2026 AEDT
Key Points
Largest international opto-electronic cervical screening study with nearly 15,000 women
TruScreen shows higher sensitivity and negative predictive value than Liquid Based Cytology
Performance comparable to high-risk HPV DNA testing for detecting severe precancerous lesions
Study published in respected BMC Cancer journal and endorsed by Chinese medical associations
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TRUSCREEN (ASX:TRU)
OPEN ARTICLE